Tepadina (thiotepa) 100 mg: possible risk of defective vials in batches n°1709192/1, n°1709192/2 and n°1709192/3 presenting a crimp seal not properly fixed on the vial

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
Tepadina
Active substance
thiotepa
Therapeutic area (MeSH)
Hematopoietic Stem Cell Transplantation
DHPC type
Quality defect
Human ATC code
L01AC01
Dissemination date
01/06/2020

How useful was this page?

Add your rating